Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 10/2011

01-10-2011 | Original Article

Integrated SPECT/CT for assessment of haemodynamically significant coronary artery lesions in patients with acute coronary syndrome

Authors: Shmuel Rispler, Doron Aronson, Sobhi Abadi, Ariel Roguin, Ahuva Engel, Rafael Beyar, Ora Israel, Zohar Keidar

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 10/2011

Login to get access

Abstract

Purpose

Early risk stratification in patients with non-ST elevation acute coronary syndromes (NSTE-ACS) is important since the benefit from more aggressive and costly treatment strategies is proportional to the risk of adverse clinical events. In the present study we assessed whether hybrid single photon emission computed tomography (SPECT)/coronary computed tomography angiography (CCTA) technology could be an appropriate tool in stratifying patients with NSTE-ACS.

Methods

SPECT/CCTA was performed in 90 consecutive patients with NSTE-ACS. The Thrombolysis in Myocardial Infarction risk score (TIMI-RS) was used to classify patients as low- or high-risk. Imaging was performed using SPECT/CCTA to identify haemodynamically significant lesions defined as >50% stenosis on CCTA with a reversible perfusion defect on SPECT in the corresponding territory.

Results

CCTA demonstrated at least one lesion with >50% stenosis in 35 of 40 high-risk patients (87%) as compared to 14 of 50 low-risk patients (35%; TIMI-RS <3; p <0.0001). Of the 40 high-risk and 50 (16%) low-risk TIMI-RS patients, 16 (40%) and 8 (16%), respectively, had haemodynamically significant lesions (p = 0.01). Patients defined as high-risk by a high TIMI-RS, a positive CCTA scan or both (n = 45) resulted in a sensitivity of 95%, specificity of 49%, PPV of 35% and NPV of 97% for having haemodynamically significant coronary lesions. Those with normal perfusion were spared revascularization procedures, regardless of their TIMI-RS.

Conclusion

Noninvasive assessment of coronary artery disease by SPECT/CCTA may play an important role in risk stratification of patients with NSTE-ACS by better identifying the subgroup requiring intervention.
Literature
1.
go back to reference Cohen M, Antman EM, Murphy SA, Radley D. Mode and timing of treatment failure (recurrent ischemic events) after hospital admission for non-ST segment elevation acute coronary syndromes. Am Heart J. 2002;143(1):63–9. doi:10.1067/mhj.2002.119767.PubMedCrossRef Cohen M, Antman EM, Murphy SA, Radley D. Mode and timing of treatment failure (recurrent ischemic events) after hospital admission for non-ST segment elevation acute coronary syndromes. Am Heart J. 2002;143(1):63–9. doi:10.​1067/​mhj.​2002.​119767.PubMedCrossRef
3.
go back to reference Antman EM, Cohen M, McCabe C, Goodman SG, Murphy SA, Braunwald E. Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE. Eur Heart J. 2002;23(4):308–14. doi:10.1053/euhj.2001.2779.PubMedCrossRef Antman EM, Cohen M, McCabe C, Goodman SG, Murphy SA, Braunwald E. Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE. Eur Heart J. 2002;23(4):308–14. doi:10.​1053/​euhj.​2001.​2779.PubMedCrossRef
4.
go back to reference Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344(25):1879–87.PubMedCrossRef Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344(25):1879–87.PubMedCrossRef
5.
go back to reference Morrow DA, Antman EM, Snapinn SM, McCabe CH, Theroux P, Braunwald E. An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS. Eur Heart J. 2002;23(3):223–9. doi:10.1053/euhj.2001.2738.PubMedCrossRef Morrow DA, Antman EM, Snapinn SM, McCabe CH, Theroux P, Braunwald E. An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS. Eur Heart J. 2002;23(3):223–9. doi:10.​1053/​euhj.​2001.​2738.PubMedCrossRef
6.
go back to reference Bhatt DL, Roe MT, Peterson ED, Li Y, Chen AY, Harrington RA, et al. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA. 2004;292(17):2096–104. doi:10.1001/jama.292.17.2096.PubMedCrossRef Bhatt DL, Roe MT, Peterson ED, Li Y, Chen AY, Harrington RA, et al. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA. 2004;292(17):2096–104. doi:10.​1001/​jama.​292.​17.​2096.PubMedCrossRef
7.
go back to reference Fox KA, Goodman SG, Anderson Jr FA, Granger CB, Moscucci M, Flather MD et al. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Eur Heart J. 2003;24(15):1414–24. doi:10.1016/S0195-668X(03)00315-4.PubMedCrossRef Fox KA, Goodman SG, Anderson Jr FA, Granger CB, Moscucci M, Flather MD et al. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Eur Heart J. 2003;24(15):1414–24. doi:10.​1016/​S0195-668X(03)00315-4.PubMedCrossRef
8.
go back to reference Boersma E, Harrington RA, Moliterno DJ, White H, Theroux P, Van de Werf F, et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet. 2002;359(9302):189–98. doi:10.1016/S0140-6736(02)07442-1.CrossRef Boersma E, Harrington RA, Moliterno DJ, White H, Theroux P, Van de Werf F, et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet. 2002;359(9302):189–98. doi:10.​1016/​S0140-6736(02)07442-1.CrossRef
9.
go back to reference Heeschen C, Hamm CW, Goldmann B, Deu A, Langenbrink L, White HD. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management. Lancet. 1999;354(9192):1757–62. doi:10.1016/S0140-6736(99)10285-X.PubMedCrossRef Heeschen C, Hamm CW, Goldmann B, Deu A, Langenbrink L, White HD. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management. Lancet. 1999;354(9192):1757–62. doi:10.​1016/​S0140-6736(99)10285-X.PubMedCrossRef
10.
go back to reference Lindahl B, Venge P, Wallentin L. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. J Am Coll Cardiol. 1997;29(1):43–8. doi:10.1016/S0735-1097(96)00447-0.PubMedCrossRef Lindahl B, Venge P, Wallentin L. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. J Am Coll Cardiol. 1997;29(1):43–8. doi:10.​1016/​S0735-1097(96)00447-0.PubMedCrossRef
11.
go back to reference Hoffmann U, Bamberg F, Chae CU, Nichols JH, Rogers IS, Seneviratne SK, et al. Coronary computed tomography angiography for early triage of patients with acute chest pain: the ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) trial. J Am Coll Cardiol. 2009;53(18):1642–50. doi:10.1016/j.jacc.2009.01.052.PubMedCrossRef Hoffmann U, Bamberg F, Chae CU, Nichols JH, Rogers IS, Seneviratne SK, et al. Coronary computed tomography angiography for early triage of patients with acute chest pain: the ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) trial. J Am Coll Cardiol. 2009;53(18):1642–50. doi:10.​1016/​j.​jacc.​2009.​01.​052.PubMedCrossRef
12.
go back to reference Rispler S, Keidar Z, Ghersin E, Roguin A, Soil A, Dragu R, et al. Integrated single-photon emission computed tomography and computed tomography coronary angiography for the assessment of hemodynamically significant coronary artery lesions. J Am Coll Cardiol. 2007;49(10):1059–67. doi:10.1016/j.jacc.2006.10.069.PubMedCrossRef Rispler S, Keidar Z, Ghersin E, Roguin A, Soil A, Dragu R, et al. Integrated single-photon emission computed tomography and computed tomography coronary angiography for the assessment of hemodynamically significant coronary artery lesions. J Am Coll Cardiol. 2007;49(10):1059–67. doi:10.​1016/​j.​jacc.​2006.​10.​069.PubMedCrossRef
13.
go back to reference Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000;284(7):835–42. doi:10.1001/jama.284.7.835.PubMedCrossRef Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000;284(7):835–42. doi:10.​1001/​jama.​284.​7.​835.PubMedCrossRef
14.
go back to reference Bugiardini R, Manfrini O, De Ferrari GM. Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography. Arch Intern Med. 2006;166(13):1391–5. doi:10.1001/archinte.166.13.1391.PubMedCrossRef Bugiardini R, Manfrini O, De Ferrari GM. Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography. Arch Intern Med. 2006;166(13):1391–5. doi:10.​1001/​archinte.​166.​13.​1391.PubMedCrossRef
15.
16.
go back to reference Samaha FF, Kimmel SE, Kizer JR, Goyal A, Wade M, Boden WE. Usefulness of the TIMI risk score in predicting both short- and long-term outcomes in the Veterans Affairs Non-Q-Wave Myocardial Infarction Strategies In-Hospital (VANQWISH) Trial. Am J Cardiol. 2002;90(9):922–6. doi:10.1016/S0002-9149(02)02654-1.PubMedCrossRef Samaha FF, Kimmel SE, Kizer JR, Goyal A, Wade M, Boden WE. Usefulness of the TIMI risk score in predicting both short- and long-term outcomes in the Veterans Affairs Non-Q-Wave Myocardial Infarction Strategies In-Hospital (VANQWISH) Trial. Am J Cardiol. 2002;90(9):922–6. doi:10.​1016/​S0002-9149(02)02654-1.PubMedCrossRef
17.
go back to reference F Ragmin and Fast Revascularisation during InStability in Coronary artery disease (FRISC II) Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Lancet. 1999;354(9180):708–15. doi:10.1016/S0140-6736(99)07349-3.CrossRef F Ragmin and Fast Revascularisation during InStability in Coronary artery disease (FRISC II) Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Lancet. 1999;354(9180):708–15. doi:10.​1016/​S0140-6736(99)07349-3.CrossRef
18.
go back to reference Sabatine MS, Morrow DA, Giugliano RP, Murphy SA, Demopoulos LA, DiBattiste PM, et al. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial. Circulation. 2004;109(7):874–80. doi:10.1161/01.CIR.0000112604.74713.35.PubMedCrossRef Sabatine MS, Morrow DA, Giugliano RP, Murphy SA, Demopoulos LA, DiBattiste PM, et al. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial. Circulation. 2004;109(7):874–80. doi:10.​1161/​01.​CIR.​0000112604.​74713.​35.PubMedCrossRef
19.
go back to reference Santana CA, Garcia EV, Faber TL, Sirineni GK, Esteves FP, Sanyal R, et al. Diagnostic performance of fusion of myocardial perfusion imaging (MPI) and computed tomography coronary angiography. J Nucl Cardiol. 2009;16(2):201–11. doi:10.1007/s12350-008-9019-z.PubMedCrossRef Santana CA, Garcia EV, Faber TL, Sirineni GK, Esteves FP, Sanyal R, et al. Diagnostic performance of fusion of myocardial perfusion imaging (MPI) and computed tomography coronary angiography. J Nucl Cardiol. 2009;16(2):201–11. doi:10.​1007/​s12350-008-9019-z.PubMedCrossRef
20.
go back to reference Faber TL, Santana CA, Garcia EV, Candell-Riera J, Folks RD, Peifer JW, et al. Three-dimensional fusion of coronary arteries with myocardial perfusion distributions: clinical validation. J Nucl Med. 2004;45(5):745–53.PubMed Faber TL, Santana CA, Garcia EV, Candell-Riera J, Folks RD, Peifer JW, et al. Three-dimensional fusion of coronary arteries with myocardial perfusion distributions: clinical validation. J Nucl Med. 2004;45(5):745–53.PubMed
21.
go back to reference Gaemperli O, Schepis T, Kalff V, Namdar M, Valenta I, Stefani L, et al. Validation of a new cardiac image fusion software for three-dimensional integration of myocardial perfusion SPECT and stand-alone 64-slice CT angiography. Eur J Nucl Med Mol Imaging. 2007;34(7):1097–106. doi:10.1007/s00259-006-0342-9.PubMedCrossRef Gaemperli O, Schepis T, Kalff V, Namdar M, Valenta I, Stefani L, et al. Validation of a new cardiac image fusion software for three-dimensional integration of myocardial perfusion SPECT and stand-alone 64-slice CT angiography. Eur J Nucl Med Mol Imaging. 2007;34(7):1097–106. doi:10.​1007/​s00259-006-0342-9.PubMedCrossRef
22.
go back to reference Mehta RH, Eagle KA. Missed diagnoses of acute coronary syndromes in the emergency room – continuing challenges. N Engl J Med. 2000;342(16):1207–10.PubMedCrossRef Mehta RH, Eagle KA. Missed diagnoses of acute coronary syndromes in the emergency room – continuing challenges. N Engl J Med. 2000;342(16):1207–10.PubMedCrossRef
23.
go back to reference Pope JH, Aufderheide TP, Ruthazer R, Woolard RH, Feldman JA, Beshansky JR, et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med. 2000;342(16):1163–70.PubMedCrossRef Pope JH, Aufderheide TP, Ruthazer R, Woolard RH, Feldman JA, Beshansky JR, et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med. 2000;342(16):1163–70.PubMedCrossRef
25.
go back to reference Heller GV, Stowers SA, Hendel RC, Herman SD, Daher E, Ahlberg AW, et al. Clinical value of acute rest technetium-99m tetrofosmin tomographic myocardial perfusion imaging in patients with acute chest pain and nondiagnostic electrocardiograms. J Am Coll Cardiol. 1998;31(5):1011–7. doi:10.1016/S0735-1097(98)00057-6.PubMedCrossRef Heller GV, Stowers SA, Hendel RC, Herman SD, Daher E, Ahlberg AW, et al. Clinical value of acute rest technetium-99m tetrofosmin tomographic myocardial perfusion imaging in patients with acute chest pain and nondiagnostic electrocardiograms. J Am Coll Cardiol. 1998;31(5):1011–7. doi:10.​1016/​S0735-1097(98)00057-6.PubMedCrossRef
26.
go back to reference Wallentin L, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease. Lancet. 2000;356(9223):9–16.PubMedCrossRef Wallentin L, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease. Lancet. 2000;356(9223):9–16.PubMedCrossRef
27.
go back to reference Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction – summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2002;40(7):1366–74. doi:10.1016/S0735-1097(02)02336-7.PubMedCrossRef Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction – summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2002;40(7):1366–74. doi:10.​1016/​S0735-1097(02)02336-7.PubMedCrossRef
28.
go back to reference Schulman KA, Berlin JA, Harless W, Kerner JF, Sistrunk S, Gersh BJ, et al. The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med. 1999;340(8):618–26.PubMedCrossRef Schulman KA, Berlin JA, Harless W, Kerner JF, Sistrunk S, Gersh BJ, et al. The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med. 1999;340(8):618–26.PubMedCrossRef
29.
go back to reference Sharis PJ, Cannon CP, Rogers WJ, McCabe C, Murphy S, Gibson CM, et al. Predictors of mortality, coronary angiography, and revascularization in unstable angina pectoris and acute non-ST elevation myocardial infarction (the TIMI III Registry). Am J Cardiol. 2002;90(10):1154–6. doi:10.1016/S0002-9149(02)02788-1.PubMedCrossRef Sharis PJ, Cannon CP, Rogers WJ, McCabe C, Murphy S, Gibson CM, et al. Predictors of mortality, coronary angiography, and revascularization in unstable angina pectoris and acute non-ST elevation myocardial infarction (the TIMI III Registry). Am J Cardiol. 2002;90(10):1154–6. doi:10.​1016/​S0002-9149(02)02788-1.PubMedCrossRef
30.
go back to reference Zia MI, Goodman SG, Peterson ED, Mulgund J, Chen AY, Langer A, et al. Paradoxical use of invasive cardiac procedures for patients with non-ST segment elevation myocardial infarction: an international perspective from the CRUSADE Initiative and the Canadian ACS Registries I and II. Can J Cardiol. 2007;23(13):1073–9.PubMedCrossRef Zia MI, Goodman SG, Peterson ED, Mulgund J, Chen AY, Langer A, et al. Paradoxical use of invasive cardiac procedures for patients with non-ST segment elevation myocardial infarction: an international perspective from the CRUSADE Initiative and the Canadian ACS Registries I and II. Can J Cardiol. 2007;23(13):1073–9.PubMedCrossRef
31.
go back to reference Jedrzkiewicz S, Goodman SG, Yan RT, Welsh RC, Kornder J, DeYoung JP, et al. Temporal trends in the use of invasive cardiac procedures for non-ST segment elevation acute coronary syndromes according to initial risk stratification. Can J Cardiol. 2009;25(11):e370–6.PubMedCrossRef Jedrzkiewicz S, Goodman SG, Yan RT, Welsh RC, Kornder J, DeYoung JP, et al. Temporal trends in the use of invasive cardiac procedures for non-ST segment elevation acute coronary syndromes according to initial risk stratification. Can J Cardiol. 2009;25(11):e370–6.PubMedCrossRef
34.
go back to reference Schuijf JD, Wijns W, Jukema JW, Decramer I, Atsma DE, de Roos A, et al. A comparative regional analysis of coronary atherosclerosis and calcium score on multislice CT versus myocardial perfusion on SPECT. J Nucl Med. 2006;47(11):1749–55.PubMed Schuijf JD, Wijns W, Jukema JW, Decramer I, Atsma DE, de Roos A, et al. A comparative regional analysis of coronary atherosclerosis and calcium score on multislice CT versus myocardial perfusion on SPECT. J Nucl Med. 2006;47(11):1749–55.PubMed
35.
go back to reference Shaw LJ, Heller GV, Travin MI, Lauer M, Marwick T, Hachamovitch R, et al. Cost analysis of diagnostic testing for coronary artery disease in women with stable chest pain. Economics of Noninvasive Diagnosis (END) Study Group. J Nucl Cardiol. 1999;6(6):559–69. doi:10.1016/S1071-3581(99)90091-0.PubMedCrossRef Shaw LJ, Heller GV, Travin MI, Lauer M, Marwick T, Hachamovitch R, et al. Cost analysis of diagnostic testing for coronary artery disease in women with stable chest pain. Economics of Noninvasive Diagnosis (END) Study Group. J Nucl Cardiol. 1999;6(6):559–69. doi:10.​1016/​S1071-3581(99)90091-0.PubMedCrossRef
Metadata
Title
Integrated SPECT/CT for assessment of haemodynamically significant coronary artery lesions in patients with acute coronary syndrome
Authors
Shmuel Rispler
Doron Aronson
Sobhi Abadi
Ariel Roguin
Ahuva Engel
Rafael Beyar
Ora Israel
Zohar Keidar
Publication date
01-10-2011
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 10/2011
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-011-1856-3

Other articles of this Issue 10/2011

European Journal of Nuclear Medicine and Molecular Imaging 10/2011 Go to the issue